1. World Health Organization
10 November, 2018
WHO Essential Medicines and Health Products Department
Update WHO EMP July – Dec 2014
IPC Meeting
World Bank, Washington DC, December , 2014
Dr Kees de Joncheere

2. 1- Access to Essential Medicines and other Health Technologies Area
World Health Organization
1- Access to Essential Medicines and other Health Technologies Area
10 November, 2018
a) Involvement of WHO in Ebola Response for the last 6 months: R&D activities, preparedness and response in the field.
b) Ebola and the challenges of the HS reconstruction including Pharmaceutical Systems:
c) For the Assessment of procurement agencies:
-ECSPP adopted the WHO Model quality assurance system. (MQAS)
Model inspection report
Revised product questionnaire (“interagency questionnaire”)

3. World Health Organization
1- Access to Essential Medicines and other Health Technologies Area
10 November, 2018
d) Preparation for the 10 years Good Governance in Medicines Programme;
e) Medicines Transparency Alliance (MeTA) evaluation with participating countries;
f) Preparation of the Expert Committee on Essential Medicines (April 2015):
Review of oncology medicines;
Hepatitis C Medicines;
Update TB drugs and ARV

4. 1- Access to Essential Medicines and other Health Technologies Area
g) Medicines and UHC:
Issue paper on high cost medicines and role of the HTA;
h) Preparation of the Global Action Plan on the AMR:
Meeting hosted by Norway on responsible use of antibiotics (Nov. 2014)

5. World Health Organization
2- Regulatory issues: Quality, Safety and Efficacy
10 November, 2018
a) Statement on value added of PQ; last updates on PQ for diagnostics and vaccines:
b) MSM on SSFFC October 2014;
New study on Public health and economic impact of SSFFC
Prioritized workplan
c) ICDRA: meeting in Brazil in August Pre meeting on Biosimilars.
d) NRA Assesssment Tool: Consultation January 2015